nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP2D6—breast cancer	0.156	0.538	CbGaD
Oxybutynin—CYP3A4—breast cancer	0.134	0.462	CbGaD
Oxybutynin—CYP3A5—Lapatinib—breast cancer	0.0332	0.0772	CbGbCtD
Oxybutynin—CYP2C8—Lapatinib—breast cancer	0.0319	0.0743	CbGbCtD
Oxybutynin—CYP3A4—Exemestane—breast cancer	0.0256	0.0596	CbGbCtD
Oxybutynin—CYP2C8—Raloxifene—breast cancer	0.0242	0.0563	CbGbCtD
Oxybutynin—CYP2D6—Idarubicin—breast cancer	0.0231	0.0538	CbGbCtD
Oxybutynin—CYP3A4—Letrozole—breast cancer	0.0218	0.0507	CbGbCtD
Oxybutynin—CYP3A4—Anastrozole—breast cancer	0.0194	0.0451	CbGbCtD
Oxybutynin—CYP3A4—Toremifene—breast cancer	0.0178	0.0413	CbGbCtD
Oxybutynin—CYP3A5—Tamoxifen—breast cancer	0.0166	0.0387	CbGbCtD
Oxybutynin—CYP3A4—Fulvestrant—breast cancer	0.0165	0.0384	CbGbCtD
Oxybutynin—CYP2C8—Tamoxifen—breast cancer	0.016	0.0372	CbGbCtD
Oxybutynin—CYP3A4—Thiotepa—breast cancer	0.0147	0.0342	CbGbCtD
Oxybutynin—CYP3A4—Ixabepilone—breast cancer	0.0135	0.0313	CbGbCtD
Oxybutynin—CYP3A4—Lapatinib—breast cancer	0.013	0.0301	CbGbCtD
Oxybutynin—CYP3A5—Paclitaxel—breast cancer	0.0129	0.0301	CbGbCtD
Oxybutynin—CYP3A5—Irinotecan—breast cancer	0.0128	0.0297	CbGbCtD
Oxybutynin—CYP2C8—Paclitaxel—breast cancer	0.0124	0.0289	CbGbCtD
Oxybutynin—CYP2C8—Fluorouracil—breast cancer	0.0118	0.0274	CbGbCtD
Oxybutynin—CYP2D6—Vinorelbine—breast cancer	0.0113	0.0263	CbGbCtD
Oxybutynin—CYP2D6—Tamoxifen—breast cancer	0.0102	0.0237	CbGbCtD
Oxybutynin—CYP3A4—Raloxifene—breast cancer	0.00982	0.0228	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—breast cancer	0.00936	0.0218	CbGbCtD
Oxybutynin—CYP3A4—Vinorelbine—breast cancer	0.00719	0.0167	CbGbCtD
Oxybutynin—CYP2D6—Vinblastine—breast cancer	0.00696	0.0162	CbGbCtD
Oxybutynin—CYP3A4—Tamoxifen—breast cancer	0.00649	0.0151	CbGbCtD
Oxybutynin—CYP3A4—Mitoxantrone—breast cancer	0.00633	0.0147	CbGbCtD
Oxybutynin—CYP3A4—Paclitaxel—breast cancer	0.00505	0.0117	CbGbCtD
Oxybutynin—CYP3A4—Irinotecan—breast cancer	0.00498	0.0116	CbGbCtD
Oxybutynin—CYP3A4—Vinblastine—breast cancer	0.00443	0.0103	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—breast cancer	0.00428	0.00995	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—breast cancer	0.00365	0.00849	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—breast cancer	0.00272	0.00633	CbGbCtD
Oxybutynin—CHRM3—muscle of abdomen—breast cancer	0.00151	0.344	CbGeAlD
Oxybutynin—Hexylcaine—SCN10A—breast cancer	0.000636	1	CrCbGaD
Oxybutynin—CHRM5—epithelium—breast cancer	0.000322	0.0733	CbGeAlD
Oxybutynin—CHRM5—skin of body—breast cancer	0.000307	0.0697	CbGeAlD
Oxybutynin—CYP2C8—mammary gland—breast cancer	0.000263	0.0597	CbGeAlD
Oxybutynin—CHRM1—female reproductive system—breast cancer	0.00015	0.034	CbGeAlD
Oxybutynin—CHRM3—adipose tissue—breast cancer	0.000146	0.0331	CbGeAlD
Oxybutynin—CHRM2—endocrine gland—breast cancer	0.000139	0.0316	CbGeAlD
Oxybutynin—CHRM3—female reproductive system—breast cancer	0.000134	0.0304	CbGeAlD
Oxybutynin—CYP2C8—endometrium—breast cancer	0.000131	0.0298	CbGeAlD
Oxybutynin—CHRM1—endocrine gland—breast cancer	0.000127	0.0288	CbGeAlD
Oxybutynin—CHRM3—female gonad—breast cancer	0.000122	0.0277	CbGeAlD
Oxybutynin—CYP2C8—pituitary gland—breast cancer	0.000119	0.027	CbGeAlD
Oxybutynin—CHRM3—endocrine gland—breast cancer	0.000113	0.0257	CbGeAlD
Oxybutynin—CYP2C8—female reproductive system—breast cancer	0.000109	0.0247	CbGeAlD
Oxybutynin—CYP3A5—adipose tissue—breast cancer	0.000107	0.0242	CbGeAlD
Oxybutynin—CYP2C8—endocrine gland—breast cancer	9.19e-05	0.0209	CbGeAlD
Oxybutynin—CYP3A5—female gonad—breast cancer	8.92e-05	0.0203	CbGeAlD
Oxybutynin—CYP3A5—endocrine gland—breast cancer	8.3e-05	0.0189	CbGeAlD
Oxybutynin—CYP3A4—female reproductive system—breast cancer	7.36e-05	0.0167	CbGeAlD
Oxybutynin—CYP2D6—female reproductive system—breast cancer	7.24e-05	0.0165	CbGeAlD
Oxybutynin—CYP2D6—female gonad—breast cancer	6.59e-05	0.015	CbGeAlD
Oxybutynin—CYP3A4—endocrine gland—breast cancer	6.23e-05	0.0141	CbGeAlD
Oxybutynin—CYP2D6—endocrine gland—breast cancer	6.13e-05	0.0139	CbGeAlD
Oxybutynin—Hypotension—Capecitabine—breast cancer	3.85e-05	0.000183	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—breast cancer	3.85e-05	0.000183	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—breast cancer	3.82e-05	0.000182	CcSEcCtD
Oxybutynin—Vomiting—Gemcitabine—breast cancer	3.81e-05	0.000182	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—breast cancer	3.78e-05	0.00018	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—breast cancer	3.78e-05	0.00018	CcSEcCtD
Oxybutynin—Rash—Gemcitabine—breast cancer	3.78e-05	0.00018	CcSEcCtD
Oxybutynin—Dermatitis—Gemcitabine—breast cancer	3.78e-05	0.00018	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—breast cancer	3.78e-05	0.00018	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—breast cancer	3.77e-05	0.000179	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—breast cancer	3.76e-05	0.000179	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—breast cancer	3.76e-05	0.000179	CcSEcCtD
Oxybutynin—Headache—Gemcitabine—breast cancer	3.76e-05	0.000179	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Capecitabine—breast cancer	3.75e-05	0.000179	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—breast cancer	3.75e-05	0.000179	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—breast cancer	3.75e-05	0.000179	CcSEcCtD
Oxybutynin—Vomiting—Fluorouracil—breast cancer	3.75e-05	0.000179	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—breast cancer	3.75e-05	0.000178	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—breast cancer	3.75e-05	0.000178	CcSEcCtD
Oxybutynin—Insomnia—Capecitabine—breast cancer	3.73e-05	0.000177	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—breast cancer	3.72e-05	0.000177	CcSEcCtD
Oxybutynin—Rash—Fluorouracil—breast cancer	3.72e-05	0.000177	CcSEcCtD
Oxybutynin—Dermatitis—Fluorouracil—breast cancer	3.71e-05	0.000177	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—breast cancer	3.71e-05	0.000177	CcSEcCtD
Oxybutynin—Paraesthesia—Capecitabine—breast cancer	3.7e-05	0.000176	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—breast cancer	3.7e-05	0.000176	CcSEcCtD
Oxybutynin—Hypersensitivity—Paclitaxel—breast cancer	3.7e-05	0.000176	CcSEcCtD
Oxybutynin—Headache—Fluorouracil—breast cancer	3.69e-05	0.000176	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—breast cancer	3.69e-05	0.000176	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—breast cancer	3.68e-05	0.000175	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—breast cancer	3.68e-05	0.000175	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—breast cancer	3.67e-05	0.000175	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—breast cancer	3.67e-05	0.000175	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—breast cancer	3.67e-05	0.000175	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—breast cancer	3.67e-05	0.000175	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—breast cancer	3.66e-05	0.000175	CcSEcCtD
Oxybutynin—Nausea—Mitoxantrone—breast cancer	3.66e-05	0.000174	CcSEcCtD
Oxybutynin—Nausea—Irinotecan—breast cancer	3.66e-05	0.000174	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—breast cancer	3.64e-05	0.000173	CcSEcCtD
Oxybutynin—Pain—Docetaxel—breast cancer	3.64e-05	0.000173	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—breast cancer	3.64e-05	0.000173	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—breast cancer	3.63e-05	0.000173	CcSEcCtD
Oxybutynin—Dyspepsia—Capecitabine—breast cancer	3.63e-05	0.000173	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—breast cancer	3.61e-05	0.000172	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—breast cancer	3.6e-05	0.000172	CcSEcCtD
Oxybutynin—Asthenia—Paclitaxel—breast cancer	3.6e-05	0.000172	CcSEcCtD
Oxybutynin—Decreased appetite—Capecitabine—breast cancer	3.58e-05	0.000171	CcSEcCtD
Oxybutynin—Nausea—Gemcitabine—breast cancer	3.56e-05	0.00017	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Capecitabine—breast cancer	3.56e-05	0.000169	CcSEcCtD
Oxybutynin—Fatigue—Capecitabine—breast cancer	3.55e-05	0.000169	CcSEcCtD
Oxybutynin—Pruritus—Paclitaxel—breast cancer	3.55e-05	0.000169	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—breast cancer	3.54e-05	0.000169	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—breast cancer	3.54e-05	0.000169	CcSEcCtD
Oxybutynin—Pain—Capecitabine—breast cancer	3.52e-05	0.000168	CcSEcCtD
Oxybutynin—Constipation—Capecitabine—breast cancer	3.52e-05	0.000168	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—breast cancer	3.52e-05	0.000167	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—breast cancer	3.52e-05	0.000167	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—breast cancer	3.51e-05	0.000167	CcSEcCtD
Oxybutynin—Nausea—Fluorouracil—breast cancer	3.5e-05	0.000167	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—breast cancer	3.49e-05	0.000166	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—breast cancer	3.49e-05	0.000166	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—breast cancer	3.48e-05	0.000166	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—breast cancer	3.48e-05	0.000166	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—breast cancer	3.47e-05	0.000165	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—breast cancer	3.47e-05	0.000165	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—breast cancer	3.47e-05	0.000165	CcSEcCtD
Oxybutynin—Tension—Epirubicin—breast cancer	3.45e-05	0.000164	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—breast cancer	3.44e-05	0.000164	CcSEcCtD
Oxybutynin—Diarrhoea—Paclitaxel—breast cancer	3.43e-05	0.000164	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—breast cancer	3.42e-05	0.000163	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—breast cancer	3.4e-05	0.000162	CcSEcCtD
Oxybutynin—Feeling abnormal—Capecitabine—breast cancer	3.39e-05	0.000162	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—breast cancer	3.39e-05	0.000162	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—breast cancer	3.39e-05	0.000161	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Capecitabine—breast cancer	3.37e-05	0.00016	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—breast cancer	3.37e-05	0.00016	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—breast cancer	3.36e-05	0.00016	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—breast cancer	3.34e-05	0.000159	CcSEcCtD
Oxybutynin—Dizziness—Paclitaxel—breast cancer	3.32e-05	0.000158	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—breast cancer	3.31e-05	0.000158	CcSEcCtD
Oxybutynin—Cough—Methotrexate—breast cancer	3.28e-05	0.000156	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—breast cancer	3.27e-05	0.000156	CcSEcCtD
Oxybutynin—Urticaria—Capecitabine—breast cancer	3.27e-05	0.000156	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—breast cancer	3.26e-05	0.000155	CcSEcCtD
Oxybutynin—Abdominal pain—Capecitabine—breast cancer	3.26e-05	0.000155	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—breast cancer	3.26e-05	0.000155	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—breast cancer	3.25e-05	0.000155	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—breast cancer	3.25e-05	0.000155	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—breast cancer	3.23e-05	0.000154	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—breast cancer	3.21e-05	0.000153	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—breast cancer	3.2e-05	0.000152	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—breast cancer	3.2e-05	0.000152	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—breast cancer	3.19e-05	0.000152	CcSEcCtD
Oxybutynin—Vomiting—Paclitaxel—breast cancer	3.19e-05	0.000152	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—breast cancer	3.19e-05	0.000152	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.18e-05	0.000151	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—breast cancer	3.17e-05	0.000151	CcSEcCtD
Oxybutynin—Rash—Paclitaxel—breast cancer	3.17e-05	0.000151	CcSEcCtD
Oxybutynin—Dermatitis—Paclitaxel—breast cancer	3.16e-05	0.000151	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—breast cancer	3.16e-05	0.000151	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—breast cancer	3.16e-05	0.000151	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—breast cancer	3.15e-05	0.00015	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—breast cancer	3.15e-05	0.00015	CcSEcCtD
Oxybutynin—Headache—Paclitaxel—breast cancer	3.14e-05	0.00015	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—breast cancer	3.13e-05	0.000149	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—breast cancer	3.11e-05	0.000148	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—breast cancer	3.09e-05	0.000147	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—breast cancer	3.09e-05	0.000147	CcSEcCtD
Oxybutynin—Cough—Epirubicin—breast cancer	3.07e-05	0.000146	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—breast cancer	3.07e-05	0.000146	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—breast cancer	3.07e-05	0.000146	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—breast cancer	3.05e-05	0.000145	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—breast cancer	3.05e-05	0.000145	CcSEcCtD
Oxybutynin—Infection—Methotrexate—breast cancer	3.05e-05	0.000145	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—breast cancer	3.04e-05	0.000145	CcSEcCtD
Oxybutynin—Hypersensitivity—Capecitabine—breast cancer	3.04e-05	0.000145	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—breast cancer	3.02e-05	0.000144	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—breast cancer	3.01e-05	0.000143	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—breast cancer	3.01e-05	0.000143	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—breast cancer	2.99e-05	0.000143	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—breast cancer	2.99e-05	0.000143	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—breast cancer	2.99e-05	0.000142	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—breast cancer	2.98e-05	0.000142	CcSEcCtD
Oxybutynin—Nausea—Paclitaxel—breast cancer	2.98e-05	0.000142	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—breast cancer	2.98e-05	0.000142	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.97e-05	0.000142	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—breast cancer	2.96e-05	0.000141	CcSEcCtD
Oxybutynin—Asthenia—Capecitabine—breast cancer	2.96e-05	0.000141	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—breast cancer	2.93e-05	0.00014	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—breast cancer	2.93e-05	0.000139	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—breast cancer	2.92e-05	0.000139	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—breast cancer	2.92e-05	0.000139	CcSEcCtD
Oxybutynin—Pruritus—Capecitabine—breast cancer	2.91e-05	0.000139	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—breast cancer	2.91e-05	0.000139	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—breast cancer	2.89e-05	0.000138	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—breast cancer	2.88e-05	0.000137	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—breast cancer	2.87e-05	0.000137	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—breast cancer	2.87e-05	0.000137	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—breast cancer	2.87e-05	0.000136	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—breast cancer	2.86e-05	0.000136	CcSEcCtD
Oxybutynin—Infection—Epirubicin—breast cancer	2.85e-05	0.000136	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—breast cancer	2.84e-05	0.000135	CcSEcCtD
Oxybutynin—Shock—Epirubicin—breast cancer	2.82e-05	0.000134	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—breast cancer	2.82e-05	0.000134	CcSEcCtD
Oxybutynin—Diarrhoea—Capecitabine—breast cancer	2.82e-05	0.000134	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—breast cancer	2.81e-05	0.000134	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—breast cancer	2.81e-05	0.000134	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—breast cancer	2.81e-05	0.000134	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—breast cancer	2.8e-05	0.000133	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.79e-05	0.000133	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—breast cancer	2.79e-05	0.000133	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—breast cancer	2.77e-05	0.000132	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—breast cancer	2.77e-05	0.000132	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—breast cancer	2.77e-05	0.000132	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—breast cancer	2.76e-05	0.000131	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—breast cancer	2.75e-05	0.000131	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.75e-05	0.000131	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—breast cancer	2.74e-05	0.00013	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—breast cancer	2.74e-05	0.00013	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—breast cancer	2.73e-05	0.00013	CcSEcCtD
Oxybutynin—Dizziness—Capecitabine—breast cancer	2.72e-05	0.00013	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—breast cancer	2.71e-05	0.000129	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—breast cancer	2.71e-05	0.000129	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—breast cancer	2.7e-05	0.000129	CcSEcCtD
Oxybutynin—Rash—Docetaxel—breast cancer	2.68e-05	0.000128	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—breast cancer	2.68e-05	0.000128	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—breast cancer	2.68e-05	0.000128	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—breast cancer	2.68e-05	0.000128	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—breast cancer	2.67e-05	0.000127	CcSEcCtD
Oxybutynin—Headache—Docetaxel—breast cancer	2.67e-05	0.000127	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—breast cancer	2.66e-05	0.000126	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—breast cancer	2.66e-05	0.000126	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—breast cancer	2.65e-05	0.000126	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—breast cancer	2.64e-05	0.000126	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—breast cancer	2.64e-05	0.000126	CcSEcCtD
Oxybutynin—Pain—Methotrexate—breast cancer	2.62e-05	0.000125	CcSEcCtD
Oxybutynin—Vomiting—Capecitabine—breast cancer	2.62e-05	0.000125	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.61e-05	0.000125	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—breast cancer	2.61e-05	0.000124	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—breast cancer	2.6e-05	0.000124	CcSEcCtD
Oxybutynin—Rash—Capecitabine—breast cancer	2.6e-05	0.000124	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—breast cancer	2.6e-05	0.000124	CcSEcCtD
Oxybutynin—Dermatitis—Capecitabine—breast cancer	2.6e-05	0.000124	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—breast cancer	2.59e-05	0.000123	CcSEcCtD
Oxybutynin—Headache—Capecitabine—breast cancer	2.58e-05	0.000123	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—breast cancer	2.58e-05	0.000123	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—breast cancer	2.58e-05	0.000123	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—breast cancer	2.55e-05	0.000122	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—breast cancer	2.53e-05	0.000121	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—breast cancer	2.53e-05	0.00012	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—breast cancer	2.53e-05	0.00012	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—breast cancer	2.53e-05	0.00012	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—breast cancer	2.51e-05	0.000119	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—breast cancer	2.49e-05	0.000119	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—breast cancer	2.48e-05	0.000118	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—breast cancer	2.48e-05	0.000118	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—breast cancer	2.47e-05	0.000118	CcSEcCtD
Oxybutynin—Pain—Epirubicin—breast cancer	2.45e-05	0.000117	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—breast cancer	2.45e-05	0.000117	CcSEcCtD
Oxybutynin—Nausea—Capecitabine—breast cancer	2.45e-05	0.000117	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—breast cancer	2.44e-05	0.000116	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—breast cancer	2.42e-05	0.000115	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.42e-05	0.000115	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—breast cancer	2.4e-05	0.000114	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—breast cancer	2.38e-05	0.000114	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—breast cancer	2.36e-05	0.000113	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—breast cancer	2.36e-05	0.000112	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—breast cancer	2.35e-05	0.000112	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—breast cancer	2.34e-05	0.000111	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—breast cancer	2.31e-05	0.00011	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.29e-05	0.000109	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—breast cancer	2.29e-05	0.000109	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—breast cancer	2.28e-05	0.000109	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—breast cancer	2.27e-05	0.000108	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—breast cancer	2.27e-05	0.000108	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—breast cancer	2.27e-05	0.000108	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—breast cancer	2.26e-05	0.000108	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—breast cancer	2.2e-05	0.000105	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—breast cancer	2.19e-05	0.000104	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—breast cancer	2.17e-05	0.000103	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—breast cancer	2.17e-05	0.000103	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—breast cancer	2.11e-05	0.000101	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—breast cancer	2.11e-05	0.0001	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—breast cancer	2.1e-05	0.0001	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—breast cancer	2.1e-05	9.99e-05	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—breast cancer	2.06e-05	9.81e-05	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—breast cancer	2.03e-05	9.67e-05	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—breast cancer	2.03e-05	9.66e-05	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—breast cancer	1.96e-05	9.35e-05	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—breast cancer	1.96e-05	9.32e-05	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—breast cancer	1.95e-05	9.29e-05	CcSEcCtD
Oxybutynin—Rash—Methotrexate—breast cancer	1.93e-05	9.21e-05	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—breast cancer	1.93e-05	9.2e-05	CcSEcCtD
Oxybutynin—Headache—Methotrexate—breast cancer	1.92e-05	9.15e-05	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—breast cancer	1.91e-05	9.07e-05	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—breast cancer	1.9e-05	9.04e-05	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—breast cancer	1.88e-05	8.95e-05	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—breast cancer	1.82e-05	8.69e-05	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—breast cancer	1.82e-05	8.68e-05	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—breast cancer	1.82e-05	8.65e-05	CcSEcCtD
Oxybutynin—Rash—Epirubicin—breast cancer	1.81e-05	8.62e-05	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—breast cancer	1.81e-05	8.61e-05	CcSEcCtD
Oxybutynin—Headache—Epirubicin—breast cancer	1.8e-05	8.56e-05	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—breast cancer	1.76e-05	8.36e-05	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—breast cancer	1.7e-05	8.12e-05	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—breast cancer	1.69e-05	8.04e-05	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—breast cancer	1.67e-05	7.97e-05	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—breast cancer	1.67e-05	7.97e-05	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—breast cancer	1.66e-05	7.92e-05	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—breast cancer	1.58e-05	7.51e-05	CcSEcCtD
Oxybutynin—CHRM3—Signaling Pathways—APC—breast cancer	3.85e-06	5.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—breast cancer	3.85e-06	5.88e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KIT—breast cancer	3.85e-06	5.88e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—breast cancer	3.84e-06	5.86e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NOS3—breast cancer	3.83e-06	5.84e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—breast cancer	3.82e-06	5.83e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGF—breast cancer	3.82e-06	5.83e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—breast cancer	3.82e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KIT—breast cancer	3.82e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—breast cancer	3.82e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ACHE—breast cancer	3.81e-06	5.81e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—breast cancer	3.81e-06	5.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGF—breast cancer	3.81e-06	5.81e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGF—breast cancer	3.77e-06	5.75e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—breast cancer	3.77e-06	5.75e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—JUN—breast cancer	3.76e-06	5.73e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMS—breast cancer	3.75e-06	5.73e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CTNNB1—breast cancer	3.73e-06	5.69e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.71e-06	5.66e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—breast cancer	3.71e-06	5.66e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NCOR1—breast cancer	3.71e-06	5.66e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK3—breast cancer	3.7e-06	5.65e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK3—breast cancer	3.69e-06	5.63e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAV1—breast cancer	3.68e-06	5.62e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—breast cancer	3.66e-06	5.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK3—breast cancer	3.65e-06	5.58e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—breast cancer	3.64e-06	5.56e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—breast cancer	3.63e-06	5.55e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—breast cancer	3.63e-06	5.54e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—breast cancer	3.62e-06	5.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP17A1—breast cancer	3.61e-06	5.5e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—breast cancer	3.59e-06	5.47e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ENO1—breast cancer	3.57e-06	5.44e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS1—breast cancer	3.57e-06	5.44e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK8—breast cancer	3.56e-06	5.42e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—breast cancer	3.55e-06	5.42e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—breast cancer	3.55e-06	5.41e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1—breast cancer	3.54e-06	5.4e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT2—breast cancer	3.54e-06	5.4e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—breast cancer	3.53e-06	5.39e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1—breast cancer	3.53e-06	5.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT2—breast cancer	3.53e-06	5.38e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—breast cancer	3.52e-06	5.37e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.52e-06	5.37e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A1—breast cancer	3.52e-06	5.37e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—breast cancer	3.51e-06	5.36e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2D6—breast cancer	3.5e-06	5.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—breast cancer	3.5e-06	5.34e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1—breast cancer	3.49e-06	5.33e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT2—breast cancer	3.49e-06	5.33e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ERCC2—breast cancer	3.49e-06	5.32e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—breast cancer	3.48e-06	5.3e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NCOA2—breast cancer	3.44e-06	5.24e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—breast cancer	3.41e-06	5.2e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—breast cancer	3.4e-06	5.18e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—breast cancer	3.39e-06	5.17e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SRC—breast cancer	3.37e-06	5.14e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.37e-06	5.13e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—breast cancer	3.36e-06	5.13e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SERPINE1—breast cancer	3.36e-06	5.13e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—breast cancer	3.36e-06	5.12e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	3.36e-06	5.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—breast cancer	3.35e-06	5.12e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SERPINE1—breast cancer	3.35e-06	5.11e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—FASN—breast cancer	3.33e-06	5.08e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—breast cancer	3.33e-06	5.08e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	3.32e-06	5.07e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BCHE—breast cancer	3.32e-06	5.06e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SERPINE1—breast cancer	3.32e-06	5.06e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—breast cancer	3.32e-06	5.06e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—breast cancer	3.28e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—breast cancer	3.28e-06	5.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MTHFR—breast cancer	3.28e-06	5e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC5A5—breast cancer	3.28e-06	5e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—breast cancer	3.25e-06	4.96e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NOS3—breast cancer	3.22e-06	4.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOS3—breast cancer	3.21e-06	4.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOS3—breast cancer	3.2e-06	4.88e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOS3—breast cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NQO1—breast cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC2A1—breast cancer	3.17e-06	4.83e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK3—breast cancer	3.11e-06	4.74e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	3.06e-06	4.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—breast cancer	3.05e-06	4.65e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	3.05e-06	4.65e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MDM2—breast cancer	3.04e-06	4.64e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1B1—breast cancer	3.03e-06	4.63e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MDM2—breast cancer	3.03e-06	4.63e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—breast cancer	3.03e-06	4.63e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAV1—breast cancer	3.02e-06	4.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—breast cancer	3.02e-06	4.61e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—breast cancer	3.02e-06	4.61e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RELA—breast cancer	3.02e-06	4.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	3.02e-06	4.6e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—breast cancer	3.01e-06	4.6e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RELA—breast cancer	3.01e-06	4.59e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MDM2—breast cancer	3.01e-06	4.58e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—breast cancer	3e-06	4.58e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—breast cancer	2.99e-06	4.57e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—breast cancer	2.99e-06	4.56e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RELA—breast cancer	2.98e-06	4.55e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.98e-06	4.54e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—breast cancer	2.97e-06	4.53e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—breast cancer	2.96e-06	4.52e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MTOR—breast cancer	2.96e-06	4.52e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—breast cancer	2.96e-06	4.52e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—breast cancer	2.95e-06	4.51e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MTOR—breast cancer	2.95e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—breast cancer	2.95e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—breast cancer	2.95e-06	4.5e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—breast cancer	2.94e-06	4.49e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MTOR—breast cancer	2.92e-06	4.46e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—breast cancer	2.92e-06	4.46e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—breast cancer	2.91e-06	4.44e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NCOA1—breast cancer	2.89e-06	4.42e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—STK11—breast cancer	2.85e-06	4.35e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP19A1—breast cancer	2.85e-06	4.35e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—breast cancer	2.85e-06	4.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—breast cancer	2.84e-06	4.33e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HRAS—breast cancer	2.83e-06	4.31e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HRAS—breast cancer	2.82e-06	4.3e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—breast cancer	2.81e-06	4.29e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HRAS—breast cancer	2.79e-06	4.26e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—breast cancer	2.79e-06	4.26e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NOS3—breast cancer	2.79e-06	4.25e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1B—breast cancer	2.78e-06	4.24e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1B—breast cancer	2.77e-06	4.23e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—breast cancer	2.76e-06	4.2e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—breast cancer	2.75e-06	4.19e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1B—breast cancer	2.74e-06	4.19e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—breast cancer	2.74e-06	4.18e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—breast cancer	2.72e-06	4.16e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—breast cancer	2.72e-06	4.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—breast cancer	2.72e-06	4.14e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—breast cancer	2.71e-06	4.14e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—breast cancer	2.71e-06	4.14e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—breast cancer	2.71e-06	4.13e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—breast cancer	2.7e-06	4.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—breast cancer	2.69e-06	4.1e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—breast cancer	2.69e-06	4.1e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—breast cancer	2.67e-06	4.08e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—COMT—breast cancer	2.65e-06	4.05e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—breast cancer	2.65e-06	4.05e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—JUN—breast cancer	2.65e-06	4.04e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—breast cancer	2.64e-06	4.03e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—breast cancer	2.64e-06	4.03e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—JUN—breast cancer	2.64e-06	4.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNB1—breast cancer	2.63e-06	4.01e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—breast cancer	2.62e-06	3.99e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNB1—breast cancer	2.62e-06	3.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—JUN—breast cancer	2.61e-06	3.98e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—breast cancer	2.6e-06	3.97e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ITPR1—breast cancer	2.6e-06	3.96e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNB1—breast cancer	2.59e-06	3.95e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—breast cancer	2.57e-06	3.93e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—breast cancer	2.57e-06	3.92e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—breast cancer	2.57e-06	3.92e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—breast cancer	2.57e-06	3.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—breast cancer	2.57e-06	3.91e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—breast cancer	2.56e-06	3.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—breast cancer	2.56e-06	3.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—breast cancer	2.56e-06	3.9e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—breast cancer	2.55e-06	3.89e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—breast cancer	2.55e-06	3.89e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—breast cancer	2.54e-06	3.88e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—breast cancer	2.53e-06	3.86e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—breast cancer	2.53e-06	3.85e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK8—breast cancer	2.5e-06	3.82e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—breast cancer	2.5e-06	3.81e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—breast cancer	2.5e-06	3.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK8—breast cancer	2.5e-06	3.81e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—breast cancer	2.49e-06	3.8e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—breast cancer	2.48e-06	3.78e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK8—breast cancer	2.47e-06	3.77e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—breast cancer	2.46e-06	3.76e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMS—breast cancer	2.45e-06	3.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.43e-06	3.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NCOR1—breast cancer	2.43e-06	3.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—breast cancer	2.43e-06	3.7e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—breast cancer	2.42e-06	3.7e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—breast cancer	2.39e-06	3.65e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SRC—breast cancer	2.37e-06	3.62e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HRAS—breast cancer	2.37e-06	3.62e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SRC—breast cancer	2.37e-06	3.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SRC—breast cancer	2.34e-06	3.57e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—breast cancer	2.32e-06	3.54e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—breast cancer	2.31e-06	3.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—breast cancer	2.3e-06	3.52e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A1—breast cancer	2.3e-06	3.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—breast cancer	2.29e-06	3.49e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NOS3—breast cancer	2.29e-06	3.49e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—breast cancer	2.28e-06	3.48e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—breast cancer	2.28e-06	3.48e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ERCC2—breast cancer	2.28e-06	3.48e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—breast cancer	2.27e-06	3.46e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—breast cancer	2.26e-06	3.45e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—breast cancer	2.22e-06	3.39e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK3—breast cancer	2.19e-06	3.34e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK3—breast cancer	2.18e-06	3.33e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK3—breast cancer	2.16e-06	3.29e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—breast cancer	2.15e-06	3.28e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTHFR—breast cancer	2.14e-06	3.27e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—breast cancer	2.13e-06	3.24e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—breast cancer	2.12e-06	3.24e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—breast cancer	2.12e-06	3.23e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—breast cancer	2.11e-06	3.23e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—breast cancer	2.11e-06	3.22e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—breast cancer	2.1e-06	3.2e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—breast cancer	2.09e-06	3.2e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—breast cancer	2.09e-06	3.2e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—breast cancer	2.09e-06	3.19e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—breast cancer	2.08e-06	3.17e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—breast cancer	2.07e-06	3.16e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—breast cancer	2.05e-06	3.13e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAV1—breast cancer	1.98e-06	3.02e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—breast cancer	1.97e-06	3e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—breast cancer	1.96e-06	2.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—breast cancer	1.94e-06	2.96e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—breast cancer	1.82e-06	2.78e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—breast cancer	1.81e-06	2.76e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—breast cancer	1.81e-06	2.75e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—breast cancer	1.8e-06	2.75e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.8e-06	2.75e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.78e-06	2.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—breast cancer	1.76e-06	2.68e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—breast cancer	1.75e-06	2.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—breast cancer	1.74e-06	2.66e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—breast cancer	1.72e-06	2.63e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HRAS—breast cancer	1.67e-06	2.55e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HRAS—breast cancer	1.67e-06	2.54e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HRAS—breast cancer	1.65e-06	2.52e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—breast cancer	1.6e-06	2.44e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—breast cancer	1.59e-06	2.43e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.58e-06	2.42e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—breast cancer	1.58e-06	2.41e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—breast cancer	1.57e-06	2.39e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—breast cancer	1.56e-06	2.38e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NOS3—breast cancer	1.5e-06	2.28e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—breast cancer	1.48e-06	2.26e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—breast cancer	1.47e-06	2.25e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—breast cancer	1.47e-06	2.24e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—breast cancer	1.46e-06	2.22e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.38e-06	2.11e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—breast cancer	1.37e-06	2.09e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.29e-06	1.96e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—breast cancer	1.28e-06	1.95e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—breast cancer	1.19e-06	1.82e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—breast cancer	1.05e-06	1.6e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—breast cancer	8.41e-07	1.28e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—breast cancer	6.87e-07	1.05e-05	CbGpPWpGaD
